Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 178 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 301 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 274 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 200 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 174 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 340 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 120 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 158 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 0.0 | BCD100427B001 | 156 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 0.5 | BCD100427B003 | 199 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 1.0 | BCD100427B007 | 363 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 2.0 | BCD100427B011 | 173 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 4.0 | BCD100427B015 | 194 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 8.0 | BCD100427B019 | 123 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 12.0 | BCD100427B023 | 213 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | C | 24.0 | BCD100427B027 | 88.8 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 201 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 184 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 177 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 178 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 367 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 90.7 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 210 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 0.5 | BCD100427B004 | 340 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 1.0 | BCD100427B008 | 163 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 2.0 | BCD100427B012 | 414 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 4.0 | BCD100427B016 | 178 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 8.0 | BCD100427B020 | 134 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 12.0 | BCD100427B024 | 359 | pmol/sample |
| - | PE(36:2e)/PE(36:1p) | 25OH-Chol | 24.0 | BCD100427B028 | 38 | pmol/sample |